Muscle Maker GrillOffering
The capital raising process completed on March 29th. Listing on the OTCQX is planned.
The capital raising process completed on March 29th. Listing on the OTCQX is planned.
TransCode is a pre-clinical biopharmaceutical company focused on the development and commercialization of therapeutics to treat metastatic cancer.
Bringing Trust to the $120 billion Skincare Industry
Develops targeted anti-cancer chemotherapy drugs with improved efficacy and lower side effects, currently in clinical trials at the Mayo Clinic.
to capital through the ability to raise up to $75 million, but also a greater ... provisions, hindering the issuer’s future capital raising activities. Alabama’s ...